Genomic instability
Your DNA takes damage every day, and the repair systems that fix it grow less accurate with age. When genome maintenance breaks badly, as in a group of rare inherited diseases, aging clearly speeds up — but whether ordinary wear on the genome sets the pace of normal aging is less settled, and nothing you can take has been shown to slow it.
Do the general things: exercise regularly, ideally above the minimum guideline, eat a plant-forward, Mediterranean-style diet, and protect your sleep. That advice rests on observational studies of biological-age markers, not on trials that measured DNA. Skip NAD⁺ boosters, spermidine pills and anything sold as "boosting DNA repair": none has been shown to help healthy people, and boosting repair is not automatically safe.
Your DNA is damaged constantly, and repair slips with age
Genomic instability is the first of the twelve hallmarks of aging: the slow corruption of the cell's master copy of its own instructions. DNA is under attack from outside the body (ultraviolet light, radiation, chemical pollutants) and from inside it, where ordinary metabolism throws off reactive oxygen species, unstable oxygen-containing molecules that damage whatever they touch. Cells carry an elaborate set of repair systems, but those systems become less accurate with age, so mutations and structural damage build up and push cells toward senescence (a worn-out but un-dying state) or cancer.[1]
The damage takes many forms: single chemical letters of the code altered or oxidised, the two strands of the double helix welded together, and outright breaks across both strands. Left unrepaired, these lesions stall the machinery that copies DNA and reads it into proteins. That trips internal alarms that can force the cell into senescence or programmed death, or, if the alarms fail, let it drift toward becoming a tumour.[2]
Why evolution lets the genome decay
The pattern is well documented; the explanation for it is a theory. It goes back to the nineteenth-century biologist August Weismann, who separated the germline, the egg and sperm cells that carry DNA to the next generation, from the soma, the rest of the body. The germline has to carry its DNA forward indefinitely, so it maintains it far more carefully: its mutation rates are at least ten times lower than those of body cells, and germ cells with compromised genomes are made to self-destruct rather than passed on. Body cells only have to last through the reproductive years.[3]
Comparing species fits that idea. A 2022 study sequenced intestinal tissue from 16 mammal species and found that the yearly somatic mutation rate falls as lifespan rises. Lifespans varied about 30-fold, yet the mutation load at the end of life differed only about 3-fold — as if evolution sets genome maintenance to match how long a body needs to last. The authors caution that this is a correlation: telomere shortening and protein turnover show similar links with lifespan, and non-causal explanations have not been ruled out.[4]
Broken repair speeds aging; everyday wear is a separate question
The strongest evidence that the genome matters for aging comes from rare inherited diseases that fast-forward it. In several, the broken gene encodes a helicase, an enzyme that unwinds the double helix so DNA can be copied and repaired. Werner, Bloom and Rothmund-Thomson syndromes are the textbook examples: repair fails, damage builds up early, and patients show early aging together with a high cancer risk. Cockayne syndrome, caused by faults in a system that repairs actively used genes, shows the other face of the problem: patients age prematurely, lose brain cells widely and waste away, but are not prone to cancer.[5]
Progeria (Hutchinson-Gilford progeria syndrome) attacks the genome's container instead: a malformed version of lamin, a protein lining the nucleus, deforms it and destabilises the DNA, and affected children typically die of cardiovascular disease in adolescence. It has the one approved drug on this page, lonafarnib. Its evidence comes from small trials with no placebo group: compared with matched untreated children from a separate study, 1 of 27 treated children had died after a median 2.2 years against 9 of 27 untreated, though with so few deaths the true size of the benefit is very uncertain.[6] The drug slows the disease rather than curing it, and it does not generalise to healthy adults.
That badly broken maintenance speeds aging does not mean ordinary mutation build-up sets the pace of normal aging. People who inherit a faulty DNA-copying enzyme (POLE or POLD1) collect mutations in their normal tissues at up to about seven times the usual rate, yet apart from a higher cancer risk they show no obvious premature aging, and many live into late old age. Their larger-scale genome damage (copy-number changes, rearrangements, telomere loss) is similar to other people's, so the case for those kinds of damage remains open.[7] And no human trial has shown that reducing DNA damage slows aging.
How damage in one cell becomes inflammation everywhere
The pathway that links a per-cell genome problem to body-wide aging is well mapped in cells and animals, and nothing targeting it has been tested in people for aging. It runs through cGAS-STING, a sensor that watches for DNA in the wrong place. DNA belongs inside the nucleus or inside mitochondria (the cell's power plants); the cell reads DNA floating loose in its interior fluid as a sign of a virus and switches on a powerful inflammatory program.[8]
Two age-related failures set that alarm off with no virus present. Chromosomes mis-sorted during cell division end up in small, fragile micronuclei that burst and spill DNA, a step worked out in cultured cells.[9] And damaged mitochondria leak their own DNA — one of the threads that ties mitochondrial dysfunction to inflammation. In naturally old mice, blocking the pathway with an experimental drug reduced age-related inflammation in several organs and the brain and improved tissue function; it has not been given to living people.[10]
A brief burst of this signalling is useful, because it helps clear damaged and pre-cancerous cells. The problem is chronic, low-level activation that never resolves, which feeds inflammaging, stem-cell exhaustion and tissue scarring. You may see it called an "inflammatory clock"; that phrase comes from a review of the aging ovary and is a metaphor, not a measured clock.[11]
Where it shows up as disease: blood vessels and blood
The route through the blood vessels is a well-supported chain of mechanism, but it has not been tested end to end in people. The cells lining blood vessels face both circulating DNA-damaging stressors and the constant force of blood flow, and over time they are pushed into senescence. Senescent cells pour out inflammatory signals and tissue-dissolving enzymes, known as the senescence-associated secretory phenotype (SASP), which degrade the vessel wall, reduce nitric oxide (the molecule vessels use to relax) and stiffen the arteries.[12] Stiffer arteries push up blood pressure, linking this hallmark to the territory covered under cholesterol.
A more direct human link runs through the blood. With age, some blood stem cells pick up mutations that let them out-compete their neighbours, a condition called clonal hematopoiesis of indeterminate potential (CHIP). Pooling 88 studies, all adjusted for age, people with CHIP had about 34% higher death rates from any cause, about 40% more cardiovascular events and about three-quarters more coronary heart disease; deaths from cardiovascular disease were higher only in people with larger clones, and the risk also depended on which gene was mutated. These are associations, but CHIP is the clearest measured case of an age-acquired genome change tracking with hard outcomes in people.[13]
The repair brake: a lab finding, not a treatment
Lab work suggests adult cells don't only lose repair capacity; they actively hold it down. A protein assembly called the DREAM complex keeps a large set of repair genes switched off in resting cells. In human cells, a drug that blocks the enzyme the brake depends on switched 58 of the 67 repair genes it binds back on and made the cells more resistant to DNA damage, and in mice with an accelerated-aging repair defect it reduced DNA damage in the retina.[14] Across 92 mammal species, lower DREAM activity marked the longer-lived ones, a correlation rather than a test.[15]
Beyond that correlation, this is cell-culture and mouse work. There is no human evidence that "releasing the repair brake" is safe or beneficial, and ramping up DNA repair indiscriminately carries obvious cancer risks.
What helps: the familiar habits, on observational evidence
The habits that track with slower biological aging are the same unglamorous ones that protect the rest of the body, and the evidence for them is mostly observational. Where trials have measured DNA damage directly, they mostly came up empty. Pooled trials in older or chronically ill people, most testing antioxidant vitamins or folate, found no significant drop in a standard marker of chromosome damage for most interventions apart from green tea, and only one had tested physical activity.[16] Six months of twice-weekly resistance training in 117 care-home residents aged 65–98 left chromosome damage in their cheek cells no different from a cognitive-training comparison group.[17] The likely route is that a body in good metabolic and inflammatory order generates less DNA damage, but that has not been shown in trials.
Exercise, probably more than the official minimum. In a Singapore cohort of 631 older adults, self-reported weekly activity went with a slightly younger reading on GrimAge, a DNA-methylation "clock" that estimates biological age, though only in a single snapshot; over about four years in 114 of them, no habit predicted change in the clocks.[18] A larger UK Biobank study of about 106,000 adults, with a separate dataset of about 42,000 who wore an activity tracker, measured biological age from routine blood-test scores and telomere length. The World Health Organization minimum is 600 MET-minutes a week (a MET is a multiple of resting energy use; 600 is roughly 150 minutes of moderate activity). The strongest association with slower biological aging was at 3,000 MET-minutes or more, about five times that, though some of the scores were built from mortality data, which may overstate the link. For deaths, the lowest risk went with moderate activity (600–3,000) combined with an anti-inflammatory diet and healthy sleep: about 31% lower than the least healthy pattern where activity was self-reported, and about 51% lower, much less precisely, where it was measured by the tracker.[19] This is observational, diet and sleep were self-reported, and people with healthier habits differ in many ways; no trial has set an optimal dose, so the direction is firmer than the number, but it fits what the site covers under zone 2 training, VO₂ max and resistance training.
A plant-forward diet. Diets rich in vegetables, polyphenols and unsaturated fats are associated with longer telomeres and lower inflammation, while diets high in saturated fat track with adverse changes to the chemical marks on DNA. Zinc is a cofactor for enzymes involved in DNA repair, and folate is needed to make one of DNA's building blocks.[20] Spermidine, a compound found in food, triggers the cell's recycling process and extends lifespan in animals, but the one proper human trial — 100 adults aged 60 to 90 with self-reported memory decline, taking about 0.9 mg a day for 12 months — found no effect on memory or its biomarkers, though the dose may have been too low.[21] See geroprotectors. In practice this is the Mediterranean dietary pattern, optionally with time-restricted eating and fermented foods.
Sleep. DNA repair and the brain's overnight waste clearance are thought to run hardest during sleep, which makes it, on mechanism, the most plausible lever of the three, but the human evidence is small. Among 49 doctors, those who worked overnight on-site calls had more DNA breaks in their blood cells and lower DNA-repair gene activity than colleagues who did not, even after three nights of adequate sleep, and a night of on-call sleep loss pushed both further.[22] That cross-sectional study of one profession shows disrupted sleep goes with more DNA damage, not that extra sleep protects the genome. In the Singapore cohort, short or long sleep showed no clear link with methylation-clock age, though few people reported either regularly.[23]
Drugs and supplements: none established for healthy people
The machinery that repairs DNA is the same machinery that restrains cancer, so "boost repair" is not a free action. Beyond lonafarnib, which is approved only for progeria, the candidates are lab work or small trials in patients.
- Senolytics and senomorphics. Drugs that kill senescent cells, and drugs such as rapamycin and ruxolitinib that quiet their secretions, are in human trials for specific conditions, not routine use; see cellular senescence.
- cGAS and STING blockers are animal work for aging. The only human trial so far is a small one in skin lupus, of a drug listed as targeting cGAS.[24]
- NAD⁺ precursors. NMN and NR (nicotinamide mononucleotide and nicotinamide riboside) raise blood levels of NAD⁺, a molecule that fuels several DNA-repair enzymes.[25] A durable health benefit has not followed. In a 58-person trial in people with long COVID, 2,000 mg a day of NR raised blood NAD⁺ about 2.6- to 3.1-fold but did not significantly improve cognition, fatigue, sleep or mood compared with placebo, and about half of those taking it from the start had dropped out by 20 weeks.[26] Pooling 15 NMN trials lasting 14 days to 24 weeks found no increase in side effects in the 10 that reported them, and no clear effect on weight, blood sugar or blood fats; none measured DNA damage, and there are no long-term safety data.[27] The most relevant result is a small crossover trial in nine patients with Werner syndrome, an inherited repair disease: 1,000 mg of NR a day caused no serious side effects, modestly reduced arterial stiffness and shrank skin ulcers, though one leg blood-flow measure got worse. Only six finished and the supplement maker supplied the capsules, so it is a hopeful signal, not evidence for anyone else.[28]
The gap between the elegance of the mechanism and the modesty of the proven interventions is the honest centre of this topic.
Further reading
- Schumacher B, et al. The central role of DNA damage in the ageing process. Nature 2021.[29]
- Cagan A, et al. Somatic mutation rates scale with lifespan across mammals. Nature 2022.[30]
- Robinson PS, et al. Increased somatic mutation burdens in normal human cells due to defective DNA polymerases. Nat Genet 2021 — the human counter-example: high mutation burden without overt premature aging.[31]
- Bujarrabal-Dueso A, et al. Targeting DNA damage in ageing: towards supercharging DNA repair. Nat Rev Drug Discov 2025.[32]
- Bujarrabal-Dueso A, et al. The DREAM complex functions as conserved master regulator of somatic DNA-repair capacities. Nat Struct Mol Biol 2023.[33]
- Margariti A, et al. The converging roles of nucleases and helicases in genome maintenance and the aging process. Life (Basel) 2025.[34]
- Gulen MF, et al. cGAS-STING drives ageing-related inflammation and neurodegeneration. Nature 2023.[35]
- Picos A, et al. Vascular senescence and aging: mechanisms, clinical implications, and therapeutic prospects. Biogerontology 2025.[36]
- Singh J, et al. Clonal hematopoiesis of indeterminate potential as a prognostic factor: a systematic review and meta-analysis. Blood Adv 2024.[37]
- Liu C, et al. Optimal lifestyle patterns for delaying ageing and reducing all-cause mortality: insights from the UK Biobank. Eur Rev Aging Phys Act 2024.[38]
- Shan J, et al. Lifestyle factors and DNA methylation-based aging clocks: cross-sectional and longitudinal associations in the Singapore diet and healthy aging cohort. J Prev Alzheimers Dis 2026.[39]
- Schwarz C, et al. Effects of Spermidine Supplementation on Cognition and Biomarkers in Older Adults With Subjective Cognitive Decline: A Randomized Clinical Trial. JAMA Netw Open 2022.[40]